Founded by physicians in 2006, LCTC Inc., provides an attractive source for conducting phase III-IV clinical research funded by Pharmaceutical, Biotech Companies, Contract Research Organizations or NIH funded trials. By integrating a leading, private-practice physician network, comprehensive site management and a solid patient recruitment program, LCTC Inc., provides a broad range of services fundamental to executing clinical trials expeditiously and economically. Our mission is to assist pharmaceutical companies and C.R.O.s to successfully bring new studied medication to the marketplace by providing the highest quality and cost effective Clinical Research Trials.
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients with Nonradiographic Axial Spondyloarthritis
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients with Axial…